Clinical Trial

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

Study acronym: TEN
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective is to describe eosinophil infiltration in resected (early stage) NSCLC. Secondary objectives are: * to investigate the correlation of T-Eos and B-Eos in the aforementioned patient population; * to investigate the correlation between T-Eos and overall \& disease-free survival; * to investigate the localization of T-Eos (periphery vs. center of the tumor lesions).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-08; most recent amendment 2024-01-12.
Status change: Recruiting → Active, Not Recruiting 2024-01-12
Status change: Not Yet Recruiting → Recruiting 2022-10-03
Trial Details
NCT Number NCT05537701
Lead Sponsor Centre Hospitalier Universitaire de Liege
Conditions Non-small Cell Lung Cancer
Enrollment 316 participants
Start Date 2022-10-03
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-16